West Pharmaceutical Services Inc. (WST) stock has gained 66.67% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives WST stock a score of 72 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 84. WST's rank also includes a short-term technical score of 70. The fundamental score for WST is 62. In addition to the average rating from Wall Street analysts, WST stock has a mean target price of 349.5. This means analysts expect the stock to decrease 0.74% over the next 12 months.
What's Happening with WST Stock Today
West Pharmaceutical Services Inc. (WST) stock has gained 1.73% while the S&P 500 has gained 0.11% as of 1:56 PM on Thursday, Jun 17. WST has gained $5.98 from the previous closing price of $346.11 on volume of 107,234 shares. Over the past year the S&P 500 is higher by 35.81% while WST has gained 66.67%. WST earned $5.58 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 63.14.